The American Diabetes Association (ADA) recently published a position statement on the management of diabetes at end of life and in those receiving palliative and hospice care. They stress recognition of the prevalence and associated disease burden and cost this disease state has on the aging population in long-term care and skilled nursing facilities.
In this article, the ADA focuses on preventing hypoglycemia and avoidance of sole use of sliding-scale insulin.
Link to Diabetes Care article (2/2016)
